您现在的位置: 首页> 研究主题> von Willebrand因子

von Willebrand因子

von Willebrand因子的相关文献在1999年到2022年内共计148篇,主要集中在内科学、基础医学、外科学 等领域,其中期刊论文148篇、专利文献18938篇;相关期刊74种,包括中国病理生理杂志、中国实验血液学杂志、国际检验医学杂志等; von Willebrand因子的相关文献由572位作者贡献,包括白霞、阮长耿、王兆钺等。

von Willebrand因子—发文量

期刊论文>

论文:148 占比:0.78%

专利文献>

论文:18938 占比:99.22%

总计:19086篇

von Willebrand因子—发文趋势图

von Willebrand因子

-研究学者

  • 白霞
  • 阮长耿
  • 王兆钺
  • 刘芳
  • 董宁征
  • 傅汉菁
  • 张威
  • 潘素芳
  • 王迎春
  • 王鸿利
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 曹磊; 胡恩赑; 李晓楠
    • 摘要: 目的探讨糖尿病肾病(DN)患者血清血管性血友病因子(v WF)、vWF裂解酶(ADAMTS13)的水平及其作用。方法选取健康体检者(正常对照组)50例和2型糖尿病(T2DM)组合并DN患者144例,根据尿微量白蛋白与尿肌酐比值(ACR),将患者分为单纯T2DM组(42例,ACR<30 mg/g)、微量白蛋白尿组(56例,30 mg/g≤ACR<300 mg/g),大量白蛋白尿组(46例,ACR≥300 mg/g)。采用免疫透射比浊法检测vWF水平;双抗体夹心法检测ADAMTS13水平,并检测血肌酐(sCr)、尿素氮(BUN)、糖化血红蛋白(HbA1c)、D-二聚体和纤维蛋白原(Fib)等,计算估计的肾小球滤过率(eGFR)。结果正常对照组、单纯T2DM组、微量白蛋白尿组、大量白蛋白尿组HbA1c、Fib、D-二聚体及v WF依次增加,而ADAMTS13依次降低(P<0.05)。多元线性回归分析显示,白蛋白与D-二聚体是血清v WF的影响因素,而D-二聚体是ADAMTS13水平的影响因素。ROC曲线分析显示,vWF诊断DN肾脏损伤敏感度较高,D-二聚体诊断DN肾脏损伤敏感度和特异度较均衡,特异度更有优势。结论血清vWF、ADAMTS13在糖尿病肾病的发生及发展中可能起着重要作用,其水平可以成为DN早期的诊断和预测的参考指标。
    • 李亮; 张继伟; 孙文浩; 王广; 田甜; 于淼
    • 摘要: 目的 急性缺血性脑卒中机械取栓后可溶性P选择素、血管性血友病因子(von Willebrand factor,vWF)、微栓子监测对血管再闭塞的预测作用.方法 回顾性选取我院收治的228例急性缺血性脑卒中患者,均行机械取栓治疗,根据治疗后血管再闭塞情况分为血管通畅组(163例)、再闭塞组(65例).比较2组患者临床资料、可溶性P选择素、vWF以及微栓子监测阳性情况等,采用logistic回归分析血管再闭塞的危险因素.用ROC曲线分析可溶性P选择素、vWF、微栓子监测对血管再闭塞的预测价值.结果 血管通畅组发病后取栓时间、美国国立卫生研究院卒中量表(NIHSS)评分、可溶性P选择素、vWF以及微栓子监测阳性均明显低于再闭塞组(P<0.01).logistic回归分析显示,发病后取栓时间(OR=1.627,95%CI:1.199~2.209)、NIHSS评分(OR=2.492,95%CI:1.302~4.767)、可溶性P选择素(OR=2.083,95%CI:1.338~3.244)、vWF(OR =2.547,95%CI:1.293~5.019)、微栓子阳性(OR=2.784,95%CI:1.139~6.806)是急性缺血性脑卒中患者机械取栓后血管再闭塞形成的独立危险因素(P<0.05,P<0.01).可溶性P选择素诊断截断值为57.85 μg/L,ROC曲线下面积为0.787(95% CI:0.736~0.831);vWF诊断截断值为78.32 μg/L,ROC曲线下面积为0.803(95%CI:0.773~0.841),微栓子监测的ROC曲线下面积为0.778(95%CI:0.719~0.828).微栓子监测的敏感性明显低于vWF(72.31% vs 89.23%,P<0.05),特异性明显高于可溶性P选择素、vWF(87.73% vs 76.69%、73.62%,P<0.01).结论 急性缺血性脑卒中机械取栓后可溶性P选择素、vWF、微栓子阳性均是血管再闭塞形成的独立危险因素,对于血管再闭塞的预测具有较高的诊断效能.
    • 卢欢欢; 李燕华
    • 摘要: 缺血性脑卒中(ischemic stroke,IS)是由突发的脑局部血液循环障碍引起的神经功能缺损综合征,是致残、死亡的主要原因,并严重危害人类健康[1]。血管性血友病因子裂解蛋白酶13(ADAMTS13)是含1型血小板反应蛋白的整合素和金属蛋白酶,通过切割血管性血友病因子(von willebrand factor,vWF)影响血小板黏附、聚集和炎性反应,其水平与多种疾病的发病、进展密切相关,包括:血栓性血管病、感染性疾病等[2]。
    • 陈静; 吴君仓; 张持; 黄磊
    • 摘要: 由于传统再灌注治疗的时间窗较窄且存在再灌注损伤风险,故而从病理生理学角度对缺血性卒中的发病机制展开研究,探索减轻再灌注损伤的方法.文章阐述了血管性血友病因子(von Willebrand factor,vWF)与血小板糖蛋白(platelet glycoprotein,GP)Ⅰb的功能及其在止血、血栓形成和炎症中的作用,认为通过药物阻断vWF-GP Ⅰb的相互作用可能有助于缺血性卒中的治疗,并进一步讨论了其在缺血性卒中和缺血性脑损伤中的重要临床意义.
    • 张莉; 庄梅
    • 摘要: 目的 探讨替米沙坦不同服药时间对非杓型伴清晨高血压患者24 h动态血压监测各参数及血管内皮功能的影响.方法 选择2014年9月~2015年12月贵州医科大学附属医院心内科就诊的原发性轻中度高血压患者80例,随机分为清晨服药组40例(07:00~09:00口服替米沙坦80 mg,1次/d)和夜晚服药组40例(19:00~21:00口服替米沙坦80 mg,1次/晚),疗程12周.比较2组治疗后动态血压监测参数、血压模式、血管性血友病因子(von Willebrand factor,vWF)及高敏C反应蛋白(hypersensitive C-reactive protein,hs-CRP)水平的变化.结果 与清晨服药组比较,夜晚服药组治疗后夜间平均收缩压、夜间平均舒张压、清晨平均收缩压、清晨平均舒张压水平明显降低,差异有统计学意义(P<0.05).与清晨服药组比较,夜晚服药组治疗后vWF和hs-CRP水平明显降低[(148.3±11.4)% vs (162.4±12.1)%,(2.9±0.5)mg/L vs (3.6±0.6)mg/L,P<0.05].结论 夜晚服用替米沙可降低非杓型伴清晨高血压患者的夜间及清晨血压水平、优化血压模式,并降低vWF、hs-CRP水平,而改善血管内皮功能.%Objective To study the effect of telmisartan taken at different times on 24 h ambulatoryblood pressure monitoring (ABPM) parameters and vascular endothelium functionin in patients with non-dipper and morning hypertension.Methods Eighty mild-moderate essential hypertension (EH) patients admitted to the Affiliated Hospital of Guizhou Medical University from September 2014 to December 2015 were randomly divided into morning drug taking group (n=40) and evening drug taking group (n=40).The patients in morning drug taking group took 80 mg telmisartan at h 7-9 in the morning and those in evening drug taking group took 80 mg telmisartan at h 19-21 in the evening for 12 weeks.Their ABPM parameters were recorded,their blood pressure and serum levels of von Willebrand factor (vWF) and hs-CRP were measured after treatment.Results The mean night and morning SBP and DBP were significantly lower in evening drug taking group than in morning drug taking group (P<0.05).The serum levels of vWF and hs-CRP were significantly lower in evening drug taking group than in morning drug taking group (148.3%±11.4% vs 162.4% ± 12.1%,2.9±0.5 mg/L vs 3.6±0.6 mg/L,P<0.05).Conclusion Telmisartan taken in the evening can reduce the night and morning blood pressure,serum vWF and hs-CRP levels,and improve the vascular endothelium function in patients with non-dipper and morning hypertension.
    • 陈晓娟; 卢丹; 蒋敏
    • 摘要: Pre-eclampsia (PE) is an idiopathic hypertensive disease which frequently appear during pregnancy,and it is accompanied with multiple systemic damages such as brain,heart,liver,kidney,etc..PE is the main cause of the increase of maternal and perinatal morbidity and mortality.At present,the exploration of the specific pathogenesis of PE is still unclear,but it is certain that when PE continues to deteriorate,it can only be improved by terminating the pregnancy timely.So understanding the pathogenesis of PE,preventing and treating PE in early stage is of great significance.von willebrand factor (vWF) is an important marker of endothelial cell injury,while domestic and overseas studies have shown that vWF may associate with PE.This paper makes a review about the roles of vWF in the pathogenesis of PE.%子痫前期(PE)是妊娠期特发的高血压疾病,可伴有脑、心、肝、肾等多器官损害,是导致孕产妇及围生儿病死率和死亡率升高的主要原因.目前,PE的发病机制虽尚未完全阐明,但是临床一致认为,PE患者病情加重时必须及时终止妊娠.由此可见,了解PE的发病机制,早期预防和治疗PE具有重要的临床意义.血管性血友病因子(vWF)是内皮细胞损伤的重要标志物,文献报道,vWF与PE可能具有一定相关性.笔者拟就vWF在PE发病机制中的作用进行综述.
    • 张艳秋; 周广红
    • 摘要: [目的]探讨糖尿病肾病(DN)患者血管性血友病因子(vWF)水平与颈动脉病变的相关性.[方法]比较42例DN患者(A组)、32例DN合并颈动脉病变患者(B组)和同期体检的50例健康志愿者(C组)血浆vWF水平、vWF裂解酶(vWF-CP)活性、颈动脉内膜中层厚度(cIMT)和颈动脉斑块面积检测结果差异,分析DN患者血浆vWF水平与颈动脉病变的相关性.[结果]①三组血浆vWF水平为C组(89.83±12.74)%
    • 陈普建; 余蓓蓓; 朱蔚骏
    • 摘要: [目的]探讨早期强化降压治疗对脑出血患者血肿扩大、神经功能、血管性假血友病因子(vWF)及核因子-κB(NF-κB)水平的影响.[方法]选择2013年2月至2016年2月收治的105例脑出血患者的临床资料,随机数字表法将其分为观察组(n=54)和对照组(n=51).观察组给予早期强化降压治疗,对照组则行常规降压干预,比较两组治疗前后收缩压(SBP)、神经功能评分(NIHSS)、血肿量、血浆vWF及NF-κB水平变化情况,统计比较两组血肿扩大发生率、不良反应及预后情况.[结果]与治疗前比较,两组治疗后24 h的SBP、NIHSS评分均明显下降,差异有统计学意义(P<0.05);且观察组治疗后24 h的SBP、NIHSS评分均明显低于对照组(P<0.05).与治疗前比较,对照组治疗后24 h血肿量明显增多(P<0.05);观察组治疗后24 h血肿量明显少于对照组(P<0.05).观察组血肿扩大4例(7.41%),对照组血肿扩大12例(23.53%),两组比较差异有统计学意义(χ2=7.30,P<0.05).与治疗前比较,两组治疗后5 d血浆vWF、NF-κB水平均明显下降(P<0.05);且观察组下降幅度明显大于对照组,差异有统计学意义(P<0.05).观察组预后良好率79.63%(43/54),对照组预后良好率60.78%(31/51),两组比较差异有统计学意义(χ2=4.48,P<0.05).[结论]早期强化降压治疗能有效控制脑出血患者血肿量增多,显著减少血肿扩大发生,能明显降低血浆vWF及NF-κB水平,显著改善患者神经功能.
    • 张平; 余自强; 张晓辉; 张威; 白霞; 曹丽娟; 苏健; 沙萍萍; 王兆钺
    • 摘要: Objective To explore the normal range of plasma VWF levels of healthy Chinese and to analyze the influencingtactors to VWF level.Methods To detect the levels of von Willebrand factor antigen (VWF ∶ Ag),von Willebrand factor ristocetin cofactor activity (VWF ∶ Rco),von Willebrand factor collagen binding activity (VWF∶ CB),and the factor Ⅷ coagulation activity (F Ⅷ ∶ C) by using fully automatic and standardized testing instruments and matching reagent in 70 healthy Chinese.The effects of age,ABO blood type,gender and region were also analyzed.Meanwhile,8 standard plasma samples (2 normal subjects,6 cases of type 2 VWD) confirmed by NIBSC were tested for VWF values.Results ① In 70 cases of healthy Chinese,the mean value of plasma VWF ∶ Ag,VWF ∶ Rco and VWF ∶ CB wvere (95.4± 44.9)%,(105.9±35.4)% and (89.8±28.4)%,respectively;the ratio of VWF∶ Rco/VWF∶Ag and VWF∶CB/ VWF∶ Ag was 1.18±0.25 and 1.03±0.29,respectively.③There was no statistical significance in plasma VWF values between the age ≥30 years and <30 years group (P>0.05).③The VWF∶ Rco,VWF∶ CB of type O blood group were lower than that of non-O group (t=2.074,P=0.042;t=3.949,P=0.001),but there was no statistical significance in VWF ∶ Ag,VWF ∶ Rco/VWF ∶ Ag,VWF ∶ CB/VWF ∶ Ag between the two groups (P>0.05).④There was no significant difference in VWF values between male and female groups (P>0.05).⑤The VWF∶ Ag,VWF∶ CB of the northern population (North area of Huaihe River) group were higher than that of southern population (Suzhou area) group (t=4.525,P=0.001;r=3.214,P=0.002),but VWF ∶ Rco/VWF ∶ Ag,VWF ∶ CB/VWF ∶ Ag were lower than that of southern population group(t=6.373,P=0.001;t=2.902,P=0.005),and there was no significant difference in VWF∶Rco between the two groups (t 1.598,P=0.115).⑥The VWF values of 8 standard plasma samples were in accordance with the known diagnosis.Conclusions A more integrate plasma VWF levels of healthy Chinese people were obtained for the first time by using fully automatic and standardized testing instruments.It was also found that ABO blood group and region had a significant impact on the level of VWF,while the age and gender had no significant effect.%目的 采用全自动标准化方法检测正常人血管性血友病因子(VWF)各指标并分析其影响因素.方法 采用全自动、标准化检测仪及配套试剂测定70名正常人VWF抗原(VWF∶Ag)、VWF瑞斯托霉素辅因子活性(VWF∶Rco)、VWF胶原结合试验(VWF∶CB)、凝血因子FⅧ活性(FⅧ∶C),比较年龄、ABO血型、性别及地域因素对正常人VWF各指标的影响.对英国国家生物标准与检定所(NIBSC)确认的8个标准血浆样本(2名正常人、6例2型VWD)进行VWF各项指标检测.结果 ①70名正常人血浆VWF∶Ag为(95.4+44.9)%,VWF∶ Rco为(105.9±35.4)%,VWF∶CB为(89.8±28.4)%;VWF∶Rco/VWF∶Ag比值为1.18+0.25,VWF∶CB/VWF∶Ag比值为1.03±0.29.②年龄≥30岁组与<30岁组比较,血浆VWF各指标差异均无统计学意义(P>0.05).③O型血组VWF∶Rco、VWF∶CB低于非O型血组(t=2.074,P=0.042;t=3.949,P=0.001),VWF∶Ag、VWF∶Rco/VWF∶Ag、VWF∶CB/VWF∶Ag比值差异无统计学意义(P>0.05).④男、女性组VWF各指标差异无统计学意义(P>0.05).⑤北方(淮河以北地区)组VWF∶Ag、VWF∶CB高于南方(苏州地区)组(t=4.525,P=0.001;t=3.214,P=0.002),VWF∶Rco/VWF∶Ag、VWF∶CB/VWF∶Ag比值低于南方组(t=6.373,P=0.001;t=2.902,P=0.005).VWF∶Rco差异无统计学意义(t=1.598,P>0.115).⑥8个标准血浆样本各项VWF指标检测结果符合已知诊断.结论 通过使用全自动标准化检测设备首次获得较完整的正常人血浆VWF水平检测数据;ABO血型和地域因素对VWF水平有显著影响,而年龄和性别的影响不显著.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号